99% Savings - Buy Just @1 Rs X
Gledepa MET XR 10/1000 MG Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Gledepa MET XR 10/1000 MG Tablet safe for pregnant women?
Gledepa MET XR can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Gledepa MET XR 10/1000 MG Tablet safe during breastfeeding?
Information about safety of Gledepa MET XR for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Gledepa MET XR 10/1000 MG Tablet on the Kidneys?
There can be some harmful effects on your kidneys after taking Gledepa MET XR. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Gledepa MET XR 10/1000 MG Tablet on the Liver?
The liver can be affected by Gledepa MET XR. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Gledepa MET XR only after medical advice.
What is the effect of Gledepa MET XR 10/1000 MG Tablet on the Heart?
Information about safety of Gledepa MET XR for heart is not available since scientific research on this is yet to be done.
If you are suffering from any of the following diseases, you should not take Gledepa MET XR 10/1000 MG Tablet unless your doctor advises you to do so -
Is this Gledepa MET XR 10/1000 MG Tablet habit forming or addictive?
Gledepa MET XR 10/1000 MG Tablet does not cause addiction.
Interaction between Food and Gledepa MET XR 10/1000 MG Tablet
Due to a lack of research, nothing can be said about the consequences of taking Gledepa MET XR 10/1000 MG Tablet together with food.
Interaction between Alcohol and Gledepa MET XR 10/1000 MG Tablet
Consult your doctor before consuming alcohol while taking Gledepa MET XR 10/1000 MG Tablet as it can have severe side effects.
The long-term use can lead to the deficiency of Vitamin B12, which can further lead to megaloblastic anemia. Furthermore, Long-term Metformin use can also lead to kidney and liver problems.
Gledepa MET XR should be taken with food to reduce stomach and bowel side effects, which may experience the first few weeks of treatment. Also, exercise regularly and test for sugar in your blood or urine as directed.
Yes, Gledepa MET XR is safe to use, many people have side effects at first, they usually diminish and then go away completely in a few weeks. A few people find they cannot tolerate metformin, there are other drugs but metformin is usually the first choice. It is very safe
Yes, Gledepa MET XR can cause some sleep problems, especially insomnia. On the other hand, Gledepa MET XR has proven to be useful for preventing sleep apnea. The exact relationship between Gledepa MET XR and sleep problems is still not clear, and further studies are needed for a clearer understanding.
Gledepa MET XR can be taken forever, diabetes is a progressive disease it's possible that more medication and/or insulin may eventually need to be added to the regime.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Farxiga (dapagliflozin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 278